H

HepaRegeniX GmbH

9 employees

HepaRegeniX is developing drugs for treating acute and chronic liver diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Life Science

Date founded

2017

Funding rounds raised

Total raised

$12M

from 7 investors over 7 rounds

H

HepaRegeniX GmbH raised $12M on January 21, 2020

Investors: Ascenion GmbH, High-Tech Gründerfonds, Novo Holdings and coparion

H

HepaRegeniX GmbH raised $9.4M on December 29, 2016

Investors: High-Tech Gründerfonds, Novo Holdings and coparion

FAQ